ABL Diagnostics S.A Press Releases - EIN Presswire - Press Release Distribution Service

Published on May 26, 2026 - 06:00 GMT

ABL Diagnostics et le CHRU Nancy : premier bilan positif pour le projet PREDAVIR après 6 mois

WOIPPY, FRANCE, May 26, 2026 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”) et le CHRU Nancy annoncent le succès des six premiers mois du projet PREDAVIR (PREvenir le DAnger VIRal), soutenu par le FEDER Grand Est. Les avancées …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 21, 2026 - 06:00 GMT

ABL Diagnostics Drives EMEA Expansion with VELA Diagnostics Partnership

Leveraging an annualized run-rate baseline of ~1M€ from late 2025, the Company accelerates its strategic rollout of automated CE-IVD HIV testing solutions. ABL Diagnostics SA (EPA:ABLD) WOIPPY, MOSELLE, FRANCE, May 21, 2026 /⁨EINPresswire.com⁩/ -- ABL …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on May 20, 2026 - 06:00 GMT

ABL Diagnostics Unveils Next-Generation HIV Genotyping Innovation with the Industry’s Broadest Portfolio

International HIV publication further validates the DeepChek® brand for HIV genotyping and long- & short-read NGS, reinforcing ABL’s leadership in HIV genomics. WOIPPY, FRANCE, May 20, 2026 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – “ABLD …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 20, 2026 - 06:00 GMT

ABL Diagnostics renforce son leadership mondial dans le génotypage VIH avec DeepChek® Whole Genome HIV

Une nouvelle publication valide la technologie DeepChek® et confirme la position de leader d’ABL Diagnostics dans le génotypage VIH et les solutions NGS WOIPPY, FRANCE, May 20, 2026 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 18, 2026 - 06:00 GMT

ABL Diagnostics Announces Strategic AI Roadmap to Advance Molecular Research and Global Data Security

WOIPPY, FRANCE, May 18, 2026 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), a specialist in molecular diagnostics, bioinformatics and infectious disease solutions, today announces its strategic commitment to integrating Artificial …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on May 12, 2026 - 06:00 GMT

ABL Diagnostics annonce le développement d’un nouveau panel syndromique intégrant la détection du hantavirus par PCR

WOIPPY, FRANCE, May 12, 2026 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (ABLD) annonce le développement d’un nouveau panel syndromique de diagnostic moléculaire intégrant la détection du hantavirus par technologie de PCR en temps réel, afin de répondre aux …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on April 15, 2026 - 16:00 GMT

Advanced Biological Laboratories (ABL) S.A. Announces Entry of a New Private Investor

Strengthening the Shareholder Base of a Long‑Term Life‑Sciences Platform LUXEMBOURG VILLE, LUXEMBOURG, April 15, 2026 /⁨EINPresswire.com⁩/ -- Advanced Biological Laboratories (ABL) S.A. (“ABL Luxembourg”) announces the entry of a new private investor …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on April 13, 2026 - 12:10 GMT

ABL Diagnostics Announces Two New Scientific Publications, Reinforcing its Expertise in HIV Sequencing-based Genotyping

WOIPPY, FRANCE, April 13, 2026 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), an innovative company specialized in microbiology and pathogen sequencing, announces the presentation of two new scientific studies at leading international …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on March 20, 2026 - 07:00 GMT

ABL Diagnostics Expands HIV Sequencing Expertise into TB Drug Resistance Profiling with New NGS Solutions

WOIPPY, FRANCE, March 20, 2026 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), an innovative company specialized in microbiology and pathogen sequencing, today announced major advancements in its Mycobacterium tuberculosis (MTB) portfolio …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on March 11, 2026 - 07:00 GMT

Peer‑Reviewed Study Confirms ABL Diagnostics’ CE‑IVD Whole‑Genome HIV‑1 Assay as a Global First

Independent clinical validation strengthens ABL’s leadership in the fast‑growing HIV drug‑resistance testing market ABL Diagnostics SA (EPA:ABLD – ISIN : FR001400AHX6) WOIPPY, MOSELLE, FRANCE, March 11, 2026 /⁨EINPresswire.com⁩/ -- ABL Diagnostics ( …

Distribution channels: Business & Economy, Companies ...

Published on February 18, 2026 - 17:00 GMT

ABL Diagnostics and CDL Pharma secure a multi year renewal of clinical services with a long standing Pharma partner

The multi‑year renewal strengthens ABL’s integrated platform, improving revenue visibility and supporting the Group’s intra‑portfolio strategy ABL Diagnostics SA (EPA:ABLD – ISIN : FR001400AHX6) WOIPPY, MOSELLE, FRANCE, February 18, 2026 /⁨EINPresswire. …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on February 13, 2026 - 17:00 GMT

ABL Luxembourg Executes First Purchase Notice With Alumni Capital Under Its Equity Line and Share Loan Agreement

First tranche completed with the sale of 128,026 ABL Diagnostics shares to Alumni Capital, marking the operational launch of the Agreement. ABL Diagnostics SA (EPA:ABLD) LUXEMBOURG VILLE, LUXEMBOURG, February 13, 2026 /⁨EINPresswire.com⁩/ -- ABL …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on January 29, 2026 - 07:00 GMT

ABL Diagnostics Appoints Helix2 as Exclusive Distributor in Greece

WOIPPY, FRANCE, January 29, 2026 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), an innovative company specialized in microbiology and pathogen sequencing, is pleased to announce the signature of an exclusive distribution agreement with …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on January 28, 2026 - 07:00 GMT

ABL Diagnostics Strengthens Strategic Supplier Agreements to Support Accelerated Growth

WOIPPY, FRANCE, January 28, 2026 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), an innovative company specialized in microbiology and pathogen sequencing, announces the reinforcement of its strategic agreements with leading global life …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on January 27, 2026 - 17:00 GMT

All Invest Securities Flash Update to the Equity Research Coverage of ABL Diagnostics (For Professional Investors)

Strong Buy reiterated with a €8.37 target price following the 21 January 2026 Flash; last close on 22 January 2026: €3.30 (ISIN: FR001400AHX6, Ticker: ABLD) ABL Diagnostics SA (EPA:ABLD) WOIPPY, MOSELLE, FRANCE, January 27, 2026 /⁨EINPresswire.com⁩/ -- …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on December 22, 2025 - 07:00 GMT

ABL Diagnostics Announces Verification of Influenza A H3N2 Detection Across UltraGene and DeepChek® Assays

Confirmation than UltraGene qPCR and DeepChek/MicrobioChek NGS for H3N2 enable research detection & genotyping to support influenza surveillance. ABL Diagnostics SA (EPA:ABLD) WOIPPY, MOSELLE, FRANCE, December 22, 2025 /⁨EINPresswire.com⁩/ -- ABL …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on December 19, 2025 - 07:00 GMT

Advanced Biological Laboratories Signs Non-Binding LOI for Proposed Reverse Merger with ProPhase Labs

Proposed transaction aims to deliver near-term value for ProPhase shareholders, long-term growth for ABL, and create a global, innovation-driven company. PROPHASE LABS (NASDAQ:PRPH) LUXEMBOURG VILLE, LUXEMBOURG, December 19, 2025 /⁨EINPresswire.com⁩/ -- …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on December 15, 2025 - 07:00 GMT

ABL Diagnostics présente trois nouvelles communications scientifiques à la RICAI 2025

WOIPPY, FRANCE, December 15, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), société innovante spécialisée dans la microbiologie et le séquençage de pathogènes annonce la présentation de trois posters scientifiques à la 45ᵉ Réunion …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on December 8, 2025 - 07:00 GMT

ABL Diagnostics and Riken Genesis: Update on the 2025 Collaboration Following Exclusive Distribution Agreement

WOIPPY, JAPAN, December 8, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext listed company specializing in molecular diagnostics, provides an update on its collaboration with Riken Genesis Co., Ltd. in Japan …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on November 24, 2025 - 07:00 GMT

ABL Diagnostics Announces Partnership with seqWell to Advance NGS Library Preparation for Infectious Disease

WOIPPY, FRANCE, November 24, 2025 /⁨EINPresswire.com⁩/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce a new partnership with seqWell to develop, validate, license, and …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...